A new study from the University of Texas M.D. Anderson Cancer Center published in the International Journal of Oncology shows that homeopathic remedies can be effective at killing breast cancer cells. This lends support to homeopathic methods of treating cancer developed by the EuroMed Foundation (www.euro-med.us), an Arizona cancer center that has been revolutionizing cancer treatment with conventional and alternative therapies. Known as The George Protocol, these treatment modalities can achieve improvement for patients with cancer and other chronic illness.

“Traditional chemotherapy and other cancer treatments tend to ravage the body, causing a lot of ‘collateral damage’ in the attempt to kill cancer cells,” explained Dr. Frank George, Medical Director Emeritus of the EuroMed Foundation and developer of The George Protocol cancer treatment alternative. “In the past, this has been seen as an unavoidable occurrence, an unfortunate side effect of medically-necessary treatments that were supposed to be effective. At EuroMed, we believe that cancer treatment can be better – targeted and non-toxic.”

Each patient at the EuroMed Foundation receives a completely individualized protocol. Different treatment modalities – such as Insulin Potentiation Therapy (IPT) – are employed to attack the cause of cancer, but also strengthen the immune system. A key factor of The George Protocol is the belief that, given the right “tools,” the body can heal itself. In addition to cancer treatments, these tools include nutrition, immune support, and detoxification.

“There has been long-standing criticism that homeopathy is ineffective,” explained Dr. George. “While we’ve seen hundreds of patients who have benefited from treatment, we’re up against continued resistance.”

“This study from M.D. Anderson provides very powerful and much-needed validation,” stated Dr. Robert Zieve of EuroMed. “M.D. Anderson is a widely respected oncology center, so the results of their study will receive a certain level of attention and recognition. This is a very exciting and positive development, because all cancer patients should know that they have options, that traditional treatments are not necessarily the only choice for them.”

The M.D. Anderson study investigated the effects of homeopathic remedies on breast cancer cells in vitro (outside the body). Referred to as “complementary and alternative medicine” (CAM), the homeopathic remedies used in the study were based on a protocol developed in India. The study found that the treatment did, in fact, kill cancer cells without damaging surrounding tissue. The authors of the study closed the article by encouraging further investigation of CAM remedies for the prevention and treatment of breast cancer.

“What the authors of the study discovered about CAM for breast cancer, we have long understood for many types of cancer – including lung, colon, lymphoma, and prostate, just to name a few,” adds Dr. Zieve. “I believe that further studies will demonstrate the vast possibilities for homeopathic and holistic cancer treatment so that the medical community and the public will have a better understanding of this revolutionary approach.”

The EuroMed Foundation (www.euro-med.us) is an Arizona cancer center specializing in the detection, diagnosis, and treatment of cancer utilizing the best of conventional and alternative therapies from around the world. The doctors on staff are all highly trained in alternative cancer therapies. Dr. Frank George researched the effects of traditional cancer treatments on the human body and developed his own protocol for a safer, more effective treatment and recovery process. Before becoming certified as an IPT instructor, Dr. George received his Doctor of Osteopathy degree at the Chicago College of Osteopathic Medicine.

Women use birth control treatments for a variety of reasons: first and foremost to avoid getting pregnant, but also to lessen premenstrual symptoms, control acne, regulate menstrual cycles and more. Unfortunately, by doing so they could actually be putting themselves at risk.

Tens of thousands of lawsuits have been filed against Bayer Corporation (manufacturer of the popular birth control pills Yaz – aka Yasmin and Ocella) and other pharmaceutical companies by women who have developed deep vein thrombosis (blood clots), strokes, gallbladder disease, pancreatitis, benign liver tumors and more after using various female contraceptives.

The complaints filed in these cases allege that the injuries these women suffered were the direct result of active and/or inactive ingredients in their birth control. The majority of Yaz/Yasmin/Ocella-related cases allege links between the harm suffered and a specific ingredient, a hormone called drosperinone, that functions as a diuretic and can markedly increase the body’s potassium levels.

Have Other Contraceptive Methods Caused Similar Problems?

While personal injury claims connected to Yaz have only recently begun to be filed, other birth control pills and methods that have caused serious complications in countless women over the years. Even the non-fatal side effects of contraceptives can do many women more harm than good, causing headaches, hair loss, vision changes, nausea, abdominal pain, edema (fluid retention), skin reactions, jaundice and more.

The contraceptive injection Depo-Provera (a shot taken every three months in lieu of having to take a daily pill), for example, when used for long periods of time, has been linked to both bone density loss and consistent weight gain. Unfortunately, bone density decreases can be permanent and have been shown to drastically increase the chance of developing osteoporosis in the future.

There have also been questions raised about the safety of Ortho Evra, a transdermal birth control patch worn for a week at a time. It contains a significantly higher amount of estrogen than many other methods. A recent study indicates that women using the patch have a greater risk of developing blood clots, thromboembolisms, pulmonary embolisms, myocardial infarctions and strokes.

Pharmaceutical companies have a duty to protect their customers, and you might be eligible for compensation if you have suffered as a result of taking Yaz, Depo-Provera, Ortho Evra or other female contraceptive products. If you or a loved one has experienced injuries related to birth control, consult an attorney in your area with in-depth knowledge of these types of cases.

Article provided by Williams, Walsh, and O’Connor, LLC
Visit us at www.williamswalshandoconnor.com

In the largest study done to date, RMA of New York’s Dr. Natan Bar-Chama and his associates presented ground-breaking research that determined men with erectile dysfunction (ED) are at a significantly increased risk of high coronary artery calcification scores (CACS), a known predictor of future cardiovascular events. This research was presented at the American Urological Association (AUA) annual meeting on May 31, 2010 in San Francisco.

The study showed that men with ED have higher CACS scores, independent of other coronary risk factors. In fact, men with ED are 50% more likely to have high CACS scores compared to those without ED. The study evaluated 1,119 consecutively enrolled men, 31% of which experienced ED, as part of the World Trade Center Medical Monitoring and Treatment Program.

“This study highlights that ED is the canary in the coal mine for underlying cardiovascular disease and, therefore, men with ED need to be evaluated for overall cardiovascular risk and guidelines are needed to define which diagnostic tests can best assess this risk,” said Dr. Bar-Chama, Director of the Center for Male Reproductive Health at Reproductive Medicine Associates of New York.

The study, titled “Erectile Dysfunction is an Independent Risk Factor for the Presence of High Risk Coronary Artery Calcification”, demonstrated this increased risk of calcification of coronary arteries, even when taking other co-morbidities and risk factors into consideration. In fact, the increased risk of coronary artery calcification for men with ED is similar to the increased risk for men with a history of hypertension or smokers. The mean age of the men in the study was 50.5 years of age.

“Identifying that ED may be an early indication of risk for a future major coronary event is but the first step in creating effective testing and early intervention, but may help us positively impact future health,” added Dr. Bar-Chama. “Certainly these findings indicate early and more thorough evaluation for ED is appropriate and it may be wise to seek the care of a urologist when first noticing the symptoms of ED.”

About The Center for Male Reproductive Health at Reproductive Medicine Associates of New York:

Led by renowned urologist, Dr. Natan Bar-Chama, the center focuses on providing innovative male reproductive and sexual health services in a professional and confidential setting. As the Director of Male Reproductive Medicine and Surgery, and an Associate Professor in the Departments of Urology, Obstetrics, Gynecology and Reproductive Sciences at the Mount Sinai School of Medicine, Dr. Bar-Chama incorporates the most up-to-date scientific insights into clinical patient care. For more information, please call 212.756.5777 or visit www.maleinfertilityny.com

About Reproductive Medicine Associates of New York (RMA of New York):
RMA of New York is the reproductive endocrinology and infertility division of Mount Sinai Medical Center and has been caring for patients at their midtown Manhattan location since 2001, with additional locations in Westchester and Long Island. RMA of New York is a full-service fertility center with international acclaim for its in vitro fertilization (IVF) program that consistently achieves high live birth rates, while maintaining low rates of triplet and higher birth outcomes. Highly individualized patient care is offered through seven reproductive endocrinologists, a urologist, a complementary care team, and highly qualified staff. RMA of New York’s clinical and laboratory teams are active researchers with the mission of translating scientific insight into clinical care. For more information, please call 212.756.5777 or visit www.rmany.com

The National Eating Disorders Association (NEDA) recently hired the integrated public relations firm ThinkCannon to handle its public relations and media outreach as well as its social media efforts. Think Cannon has already secured placements in the New York Times, as well as created strategic partnerships with such media names as ABC/Disney in just the first month. In addition, by helping to manage an aggressive digital strategy that includes strategic keyword marketing, social media outreach, and digital optimization, Think Cannon will make sure NEDA is an organization you will hear from.

The National Eating Disorders Association is one of the largest non-profit organizations working to bring an end to eating disorders. NEDA is also working to increase research funding in order to better understand and treat these illnesses. Examples of NEDA’s programs include the STAR program (States for Treatment Access and Research) that works with states legislators and government officials to fight for better treatment and to put early intervention programs into place. It also includes a series of local and national awareness Walks, as well as an ongoing outreach program called The Parent Family and Friends Network, which provides support for those struggling with an eating disorder. Additionally, NEDA toolkits for parents, educators and coaches, as well as their educational initiatives are designed to prevent and ultimately put an end to eating disorders as we know them.

“NEDA has already made great strides in raising awareness of, and supporting those affected by eating disorders,” Lynn Grefe, Chief Executive Officer of the National Eating Disorders Association said. “By bringing ThinkCannon on board, we can do even more by connecting journalists with our network of medical professionals, Ambassadors, and spokespeople. As our tagline states “It’s Time to Talk about It.”

The National Eating Disorders Association’s mission is to support those affected by eating disorders and their families and to serve as a catalyst for prevention, cures and access to quality care. In 1999, NEDA’s toll-free national hotline launched as an outlet for those suffering who needed assistance.

The organization has much in store for the upcoming fall season. NEDA is gearing up to host its second annual New York City Walk on October 3rd, 2010 as well as its Annual NEDA Conference from October 8-10, 2010 in New York, featuring keynote speaker Naomi Wolf, bestselling author of “The Beauty Myth.”

For more information, or to contact one of NEDA’s experts, please contact Jaclyn Ferrara at Think Cannon (212) 993 6464, or via email at jferrara@thinkcannon.com.

The National Eating Disorders Association (NEDA) is a non-profit organization dedicated to supporting individuals and families affected by eating disorders. We campaign for prevention, improved access to quality treatment, and increased research funding to better understand and treat eating disorders. NEDA works with partners and volunteers to develop programs and tools to help everyone who seeks assistance. Since 1999, NEDA’s national toll-free helpline has assisted families, friends and individuals find appropriate treatment. NEDA is proud that our website serves as an entry point for people around the globe to find information on eating disorders. We serve as an important and welcome first stop for those searching for resources. [www.nationaleatingdisorders.org]

Think Cannon is an integrated communications firm that helps its clients by building their brands, positioning them in the market, and driving sales through targeted public relations and communications programs.